Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.

Mestdagh N, Pommery N, Saucier JM, Hecquet B, Fournier C, Slomianny C, Teissier E, Hénichart JP.

Anticancer Res. 1994 May-Jun;14(3A):869-74.

PMID:
7915509
2.

HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.

Zwelling LA, Slovak ML, Doroshow JH, Hinds M, Chan D, Parker E, Mayes J, Sie KL, Meltzer PS, Trent JM.

J Natl Cancer Inst. 1990 Oct 3;82(19):1553-61.

PMID:
1976136
4.

Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.

Kiura K, Ohnoshi T, Tabata M, Shibayama T, Kimura I.

Acta Med Okayama. 1993 Jun;47(3):191-7.

PMID:
8104372
5.

Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.

Jain N, Lam YM, Pym J, Campling BG.

Cancer. 1996 May 1;77(9):1797-808.

7.
8.
9.
10.

P-glycoprotein but not topoisomerase II and glutathione-S-transferase-pi accounts for enhanced intracellular drug-resistance in LoVo MDR human cell lines.

Boiocchi M, Tumiotto L, Giannini F, Viel A, Biscontin G, Sartor F, Toffoli G.

Tumori. 1992 Jun 30;78(3):159-66.

PMID:
1359686
11.
12.
13.

Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.

Hatanaka H, Abe Y, Naruke M, Asai S, Miyachi H, Kawakami T, Nagata J, Kamochi J, Kijima H, Yamazaki H, Scanlon KJ, Ueyama Y, Nakamura M.

Anticancer Res. 2001 Mar-Apr;21(2A):879-85.

PMID:
11396179
14.

Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.

Chen YN, Mickley LA, Schwartz AM, Acton EM, Hwang JL, Fojo AT.

J Biol Chem. 1990 Jun 15;265(17):10073-80.

15.
16.

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.

Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller CP, Dopfer R, Klingebiel T, Diddens H, et al.

Br J Cancer. 1992 Sep;66(3):507-17.

17.
18.

Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.

Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.

Cancer Res. 1993 Nov 1;53(21):5225-32.

19.

A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin.

Supino R, Binaschi M, Capranico G, Gambetta RA, Prosperi E, Sala E, Zunino F.

Int J Cancer. 1993 May 8;54(2):309-14.

PMID:
8098017
20.

Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.

Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.

J Cell Physiol. 1994 Aug;160(2):213-26.

PMID:
7913708
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk